Skip to main content
logo
Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
7.25
+0.37 (5.38%)
Aug 25, 2026, 4:00 PM EDT - Market closed

Aardvark Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
159286---
Market Cap Growth
-25.15%----
Enterprise Value
85160---
Last Close Price
7.2513.13---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
2.122.68---
P/TBV Ratio
2.122.68---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.010.000.010.020.02
Net Debt / Equity Ratio
-0.98-1.03-1.01-1.08-0.99
Net Debt / EBITDA Ratio
0.991.753.20--
Net Debt / FCF Ratio
1.052.024.011.691.50
Quick Ratio
11.5710.4314.957.2327.07
Current Ratio
12.6310.6115.057.5027.72
Return on Equity (ROE)
-66.02%-64.44%-50.70%-57.47%-
Return on Assets (ROA)
-40.38%-40.27%-32.35%-33.96%-
Return on Capital Employed (ROCE)
-98.50%-58.80%-31.40%-81.00%-64.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-44.05%-20.15%---
FCF Yield
-43.75%-18.99%---
Buyback Yield / Dilution
-102.94%-391.06%-0.90%-1.78%-
SEC Filings: 10-K · 10-Q